Cargando…
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report
BACKGROUND: Clarithromycin is an efficacious treatment for myeloma in combination with other anti-myeloma therapy but not as monotherapy. To date, all studies have focused on a clarithromycin-specific effect rather than a class effect (macrolide) and there is no information on the activity of roxith...
Autores principales: | Chai, Kern Y., Byrne, Anna L., Morison, Ian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944102/ https://www.ncbi.nlm.nih.gov/pubmed/29743095 http://dx.doi.org/10.1186/s13256-018-1636-9 |
Ejemplares similares
-
Roxithromycin-Associated Acute Thrombocytopenia
por: Rossi, Marco, et al.
Publicado: (2021) -
Case Series Analysis of New Zealand Reports of Rapid Intense Potentiation of Warfarin by Roxithromycin
por: Savage, Ruth L., et al.
Publicado: (2018) -
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
por: Svanström, Henrik, et al.
Publicado: (2014) -
Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
por: Shimane, T, et al.
Publicado: (2001) -
A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease
por: Shafuddin, Eskandarain, et al.
Publicado: (2015)